4//SEC Filing
Brooks Michael J 4
Accession 0001654954-22-014747
CIK 0001540159other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 3:27 PM ET
Size
9.6 KB
Accession
0001654954-22-014747
Insider Transaction Report
Form 4
Brooks Michael J
President
Transactions
- Award
Common Share Warrants (Right to Buy)
2022-11-02+2,119→ 2,119 totalExercise: $1.00→ Common Shares (2,119 underlying) - Award
Common Shares
2022-11-02$1.13/sh+4,239$4,769→ 30,480 total - Award
Common Share Warrants (Right to Buy)
2022-11-02+2,119→ 2,119 totalExercise: $1.50→ Common Shares (2,119 underlying)
Footnotes (3)
- [F1]The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
- [F2]Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date.
- [F3]Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001779126
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 3:27 PM ET
- Size
- 9.6 KB